Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regional Monitoring of CF Lung Disease After Changes in Mechanical Airway-clearance Treatment
NCT06339593Phase 1Recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jan 2024
- Primary completion
- Jan 2028
- Countries
- 1
01
Overview
Phase 1, open-label trial in cystic fibrosis (CF) (3 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Functional lung abnormalities via Xenon MRI at 2 weeks. Started Jan 2024; status: recruiting.
02
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT06339593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06339593.